Josh S.

Josh Seidenfeld is a Partner at Cooley LLP, where he serves as the global chair of the firm's digital health group and is a member of the Life Sciences Advisory Board. He specializes in representing high-growth technology and healthcare companies, as well as their investors, throughout various stages of their development, from seed funding to mergers and acquisitions and initial public offerings (IPOs) .12

Professional Background

Seidenfeld has extensive experience in the life sciences and healthcare sectors, having managed over 350 venture capital financings with a total deal value exceeding $5 billion, including more than $2 billion in the past year alone. His client base spans multiple industries, including biotechnology, pharmaceuticals, climate tech, and digital health .23

Before joining Cooley, he worked at Practice Fusion, where he served as corporate counsel and director of business development. In this role, he was involved in navigating complex regulations and negotiating contracts within the digital healthcare space .2

Education and Credentials

Josh Seidenfeld holds a Juris Doctor (JD) and an MBA from Santa Clara University, both obtained in 2009, as well as a Bachelor of Science (BS) degree from the University of California, Riverside, where he graduated magna cum laude in 2005 .23

Recent Transactions

Some notable transactions he has been involved in include:

• Zephyr AI’s $111 million Series A financing
• Cellares’ $255 million Series C financing
• Rani Therapeutics’ $73 million IPO
• SoftBank Vision Fund’s $1.1 billion equity investment in Roivant Sciences .2

Seidenfeld is also a contributing editor for Cooley GO, an online resource designed for entrepreneurs and emerging companies .2